WOODBRIDGE, Conn.–(BUSINESS WIRE)–LambdaVision, a pre-clinical-stage biotech advancing on-Earth and microgravity bioprocesses, today announced the signing of a memorandum of understanding with Vast to support future research and manufacturing activit…
Author: Business Wire
Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026
AUSTIN, Texas–(BUSINESS WIRE)–Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases, today announced an oversubscribed $330 million Series B financing. The financing round was co…
The Cataltheia Group and Bruno Vision Care Announce Publication of Landmark Clinical Study Validating Deseyne® Extended Depth of Focus Technology for Presbyopia
BOCA RATON, Fla.–(BUSINESS WIRE)– #ClinicalResearch–New study in Optometry and Vision Science validates Bruno Vision Care’s Deseyne® EDOF lens technology, expanding options for presbyopia correction.
Cloudbreak Pharma Announces Results of First-of-Its-Kind Patient Survey on Pinguecula, Confirming Significant Unmet Need and Impact on Quality of Life
IRVINE, Calif.–(BUSINESS WIRE)–Cloudbreak Pharma Inc., (HKEX 2592), a clinical stage ophthalmic drug company leveraging its proprietary Multi Kinase Inhibitor (MKI) discovery platform to develop first-in-class and best-in-class therapeutics, today an…
Bayer Completes Acquisition of Perfuse Therapeutics
BERLIN–(BUSINESS WIRE)–Bayer today announced the completion of the acquisition of Perfuse Therapeutics, Inc. As a result, Perfuse Therapeutics will now be fully integrated into Bayer. As announced previously, Bayer now holds the full rights pertainin…
Emmecell Announces Closing of Strategic Financing
MENLO PARK, Calif.–(BUSINESS WIRE)–Emmecell closed a strategic financing round, including Bausch + Lomb, to advance its clinical programs and magnetic cell delivery platform.
Saptalis Pharmaceuticals Launches Cyclosporine Ophthalmic Emulsion 0.05% and Expands Product Portfolio
HAUPPAUGE, N.Y.–(BUSINESS WIRE)–Saptalis Pharmaceuticals LLC today announced the commercial launch of Cyclosporine Ophthalmic Emulsion 0.05%, available in 30- and 60-count single-use vials, reinforcing its commitment to expanding access to high-quali…
Alcon Launches UNITY® CS at COS 2026, Advancing the Next Generation of Surgical Innovation in Canada
MONTRÉAL–(BUSINESS WIRE)–Alcon announces the launch and Canadian availability of UNITY® Cataract System (CS), Alcon’s next-generation standalone cataract surgical platform
Alcon lance UNITYMD CS au Congrès de la SCO 2026, qui marque une avancée majeure dans la prochaine génération d’innovations chirurgicales au Canada
MONTRÉAL–(BUSINESS WIRE)–Alcon, le chef de file mondial en matière de soins oculaires qui se consacre à aider les gens à voir avec clarté, a annoncé aujourd’hui le lancement et la disponibilité au Canada du UNITYMD Cataract System (CS), la plateforme…
Vision Innovation Partners Appoints Dr. Brad Foster as Chief Medical and Strategy Officer
ANNAPOLIS, Md.–(BUSINESS WIRE)–Vision Innovation Partners (“VIP”), a leading Mid-Atlantic eye care platform with 69 locations, today announced that it has appointed Dr. Brad Foster as Chief Medical and Strategy Officer. The Chief Medical and Strategy…
Johnson & Johnson Invests more than $1 Billion to Strengthen U.S. Vision Manufacturing in Jacksonville, Florida
NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) (the “Company”), healthcare’s leading, most comprehensive innovation powerhouse, today announced an investment of more than $1 billion in Jacksonville, Florida to strengthen its Vi…
Eyebot Appoints Kiyo Gomi as COO to Lead Next Phase of Growth
BOSTON–(BUSINESS WIRE)–Eyebot, the automated vision test kiosk that provides doctor-verified eyeglass prescriptions, today announced Kiyo Gomi’s promotion to Chief Operating Officer. Effective immediately, Gomi will oversee company operations as Eyeb…
BrightFocus Foundation Launches “Let’s Talk Alzheimer’s” Podcast Featuring Top Experts in Alzheimer’s Research
CLARKSBURG, Md.–(BUSINESS WIRE)– #Alzheimers–New podcast features world-class experts sharing the latest Alzheimer’s and dementia research in plain language for families and caregivers.
Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL, an Advanced Lens Option for Cataract Surgeons and Patients
JACKSONVILLE, Fla.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) is expanding the U.S. roll-out of its latest advancement in presbyopia-correcting intraocular lenses (PC-IOLs). TECNIS PureSee IOL is an extended depth of focus (EDOF) lens designed…
Harley Street Health District Releases First Annual Impact Report
LONDON–(BUSINESS WIRE)–The Harley Street Health District has today launched its first annual impact report, demonstrating significant growth in market value and private healthcare activity. For the first time, The Harley Street Health District 2026 I…
Mosaic Clinical Technologies™ lanceert Mosaic Reporting™, een AI-gebaseerd rapportageplatform speciaal ontwikkeld voor radiologische werkprocessen
NASHVILLE, Tenn.–(BUSINESS WIRE)–Mosaic Clinical Technologies™, een volledige dochteronderneming van Radiology Partners, heeft vandaag de commerciële lancering aangekondigd van Mosaic Reporting™. Het gaat hier om een baanbrekende AI-gebaseerde oploss…
OpenEvidence and the American Academy of Ophthalmology Partner to Close the Gap Between Evidence and Eye Care
MIAMI & SAN FRANCISCO–(BUSINESS WIRE)– #ClinicalAI–The American Academy of Ophthalmology, the world’s largest association of eye physicians and surgeons, and OpenEvidence, the most widely used medical AI platform among U.S. physicians, today announc…
Mosaic Clinical Technologies™ Launches Mosaic Reporting™, an AI-Native Reporting Platform Built for Radiology Workflows
NASHVILLE, Tenn.–(BUSINESS WIRE)–Mosaic Clinical Technologies™, a wholly owned subsidiary of Radiology Partners, today announced the commercial launch of Mosaic Reporting™, a new class of AI-native radiology reporting solution available as part of Mo…
Dompé Doses First Patient in Phase 3 Study of Cenegermin-bkbj in PCED
MILAN & SAN MATEO, Calif.–(BUSINESS WIRE)–Dompé advances Phase 3 study of Cenegermin-bkbj (a rhNGF) for PCED, a rare condition with high unmet clinical need.
Eyebot and The Framery at 1-800 Contacts Announce Partnership in Greater Salt Lake City area, Delivering Doctor-Reviewed Glasses Prescriptions in Minutes
SALT LAKE CITY–(BUSINESS WIRE)–Eyebot and The Framery at 1-800 Contacts today announced a new partnership kicking off in The Framery’s hometown of Salt Lake City, Utah. Beginning June 3, Eyebot Kiosks will be open at Layton Hills Mall in Layton, Utah…